O'Neill A - Search Results

1

Phase II study of rituximab given in conjunction with standard chemotherapy in primary central nervous system lymphoma (PCNSL): a trial of the ECOG-ACRIN cancer research group (E1F05).

Swinnen LJ, O'Neill A, Imus PH, Gujar S, Schiff D, Kleinberg LR, Advani RH, Dunbar EM, Moore D, Grossman SA. Swinnen LJ, et al. Oncotarget. 2017 Nov 6;9(1):766-773. doi: 10.18632/oncotarget.22332. eCollection 2018 Jan 2. Oncotarget. 2017. PMID: 29416652 Free PMC article.

2

Preradiation Chemotherapy for Adult High-risk Medulloblastoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4397).

Moots PL, O'Neill A, Londer H, Mehta M, Blumenthal DT, Barger GR, Grunnet ML, Grossman S, Gilbert MR, Schiff D. Moots PL, et al. Am J Clin Oncol. 2018 Jun;41(6):588-594. doi: 10.1097/COC.0000000000000326. Am J Clin Oncol. 2018. PMID: 27635620 Free PMC article. Clinical Trial.

3

Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative Oncology Group Trial 2394.

Grossman SA, O'Neill A, Grunnet M, Mehta M, Pearlman JL, Wagner H, Gilbert M, Newton HB, Hellman R; Eastern Cooperative Oncology Group. Grossman SA, et al. J Clin Oncol. 2003 Apr 15;21(8):1485-91. doi: 10.1200/JCO.2003.10.035. J Clin Oncol. 2003. PMID: 12697871 Clinical Trial.

4

Survival of patients with newly diagnosed glioblastoma multiforme treated with RSR13 and radiotherapy: results of a phase II new approaches to brain tumor therapy CNS consortium safety and efficacy study.

Kleinberg L, Grossman SA, Carson K, Lesser G, O'Neill A, Pearlman J, Phillips P, Herman T, Gerber M. Kleinberg L, et al. J Clin Oncol. 2002 Jul 15;20(14):3149-55. doi: 10.1200/JCO.2002.01.096. J Clin Oncol. 2002. PMID: 12118029 Clinical Trial.

5

A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT & SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320: in regard to Sperduto et al.

Robins HI, O'Neill A, Mehta M, Grossman S. Robins HI, et al. Int J Radiat Oncol Biol Phys. 2013 Aug 1;86(5):809-10. doi: 10.1016/j.ijrobp.2013.03.040. Int J Radiat Oncol Biol Phys. 2013. PMID: 23845832 Free PMC article. No abstract available.

6

Charcot-Marie-Tooth gene, SBF2, associated with taxane-induced peripheral neuropathy in African Americans.

Schneider BP, Lai D, Shen F, Jiang G, Radovich M, Li L, Gardner L, Miller KD, O'Neill A, Sparano JA, Xue G, Foroud T, Sledge GW Jr. Schneider BP, et al. Oncotarget. 2016 Dec 13;7(50):82244-82253. doi: 10.18632/oncotarget.12545. Oncotarget. 2016. PMID: 27732968 Free PMC article. Clinical Trial.

7

Impact of Genetic Ancestry on Outcomes in ECOG-ACRIN-E5103.

Schneider BP, Shen F, Jiang G, O'Neill A, Radovich M, Li L, Gardner L, Lai D, Foroud T, Sparano JA, Sledge GW Jr, Miller KD. Schneider BP, et al. JCO Precis Oncol. 2017;2017:PO.17.00059. doi: 10.1200/PO.17.00059. Epub 2017 Aug 21. JCO Precis Oncol. 2017. PMID: 29333527 Free PMC article.

8

A phase II study of preradiation chemotherapy followed by external beam radiotherapy for the treatment of patients with newly diagnosed glioblastoma multiforme: an Eastern Cooperative Oncology Group study (E2393).

Gilbert M, O'Neill A, Grossman S, Grunnet M, Mehta M, Jubelirer S, Hellman R. Gilbert M, et al. J Neurooncol. 2000 Apr;47(2):145-52. doi: 10.1023/a:1006402123397. J Neurooncol. 2000. PMID: 10982156 Clinical Trial.

9

Pilot trial of paclitaxel-trastuzumab adjuvant therapy for early stage breast cancer: a trial of the ECOG-ACRIN cancer research group (E2198).

Schneider BP, O'Neill A, Shen F, Sledge GW, Thor AD, Kahanic SP, Zander PJ, Davidson NE. Schneider BP, et al. Br J Cancer. 2015 Dec 22;113(12):1651-7. doi: 10.1038/bjc.2015.405. Epub 2015 Dec 1. Br J Cancer. 2015. PMID: 26625004 Free PMC article. Clinical Trial.

10

Association of Circulating Tumor Cells With Late Recurrence of Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.

Sparano J, O'Neill A, Alpaugh K, Wolff AC, Northfelt DW, Dang CT, Sledge GW, Miller KD. Sparano J, et al. JAMA Oncol. 2018 Dec 1;4(12):1700-1706. doi: 10.1001/jamaoncol.2018.2574. JAMA Oncol. 2018. PMID: 30054636 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,034 results

Search Page

Filters